Table 1.
Baseline characteristics of subjects receiving early intervention with 5% albumin compared with standard care (RL)
| Variable | Group | |
|---|---|---|
| RL (n = 42) | Albumin 5% (n = 42) | |
| Sex, n (%) | ||
| Males | 27 (64.3) | 20 (47.6) |
| Females | 15 (35.7) | 22 (52.4) |
| Age (years), median (IQR) | 32 (23–39) | 31 (21–36) |
| Fever (days), median (IQR) | 3 (3–4) | 3 (3–4) |
| DHF Grade | ||
| I | 36 (85.7) | 38 (90.5) |
| II | 6 (14.3) | 4 (9.5) |
| Infection | ||
| Primary | 13 (31.0) | 6 (14.3) |
| Secondary | 29 (69.0) | 36 (85.7) |
| Urea (mg/dL), median (IQR) | 22 (18.5–27.25) | 23.5 (18.25–29.25) |
| Creatinine (mg/dL), median (IQR) | 0.84 (0.6–1.07) | 0.90 (0.70‒1.17) |
| Baseline serum Albumin (g/dL), median (IQR) | 3.72 (3.4–4.10) | 3.93 (3.67–4.12) |
| Baseline platelet (10³/µL), mean (SD) | 113166.6 (17266.6) | 110,642 (18,834) |
| Baseline hemoglobin (g/dL), mean (SD) | 14.33 (SD 1.46) | 13.94 (SD 1.52) |
| Baseline hematocrit (%), mean (SD) | 40.50 (SD 4.38) | 40.52 (SD 4.53) |